Keurig Dr Pepper's KDP short percent of float has fallen 6.49% since its last report. The company recently reported that it has 25.98 million shares sold short, which is 2.45% of all regular shares that are available for trading.

In the current market session, Hamilton Lane Inc. HLNE stock price is at $162.59, after a 0.07% drop. However, over the past month, the company's stock spiked by 18.28%, and in the past year, by 41.45%.

Birkenstock expected to post 17.7% revenue growth in Q2. Germany-based production shields BIRK from major tariff risks. Don't miss this list of 3 high-yield stocks-including one delivering over 10%-built for income in today's chaotic market.

Nearly 25% of HHS employees, totaling 20,000 positions, were cut despite no budget shortfall. Health services, including infectious disease testing and maternal health programs, were abruptly halted due to office closures.

Wellgistics Health, a publicly traded healthcare infrastructure firm, plans to accept payments in XRP and will add the token developed by Ripple Labs to its corporate treasury ...

Lucid shares rose nearly 5% after announcing discounts of up to $20,500 on its Air sedan amid tariff-related margin concerns. The company reported a 58% jump in deliveries and set a 2025 target of 20,000 vehicles, backed by new hires and over $1 billion in funding.

Capital Link's Trending News Webinar Series featured this week a discussion with Mr. Alexander Saverys, CEO of CMB.TECH CMBT, who shared his views on the company's diversified business model, plans for decarbonization, and his vision for a maritime industry that balances tradition with bold ...

Why so many individuals continue to struggle with skin, hair, and nail health despite topical solutions The science-backed ingredients inside NutraBoost Beauty Gummies by EverBella and how they work from within How NutraBoost supports natural collagen and elastin production for skin elasticity ...

AppLovin stock surged 12% after Q1 sales beat, rising 40% YoY to $1.48B, and EPS crushed estimates. Analysts hiked AppLovin targets, citing strong ad growth and e-commerce push despite Q2 onboarding caution. Feel unsure about the market's next move?

71.1% EASI reduction in high-dose group vs. 42.1% for placebo after 28 days. No dose-limiting toxicities or major lab abnormalities observed in any cohort. Feel unsure about the market's next move? Copy trade alerts from Matt Maley-a Wall Street veteran who consistently finds profits in volatile ...